AMSBIO (Oxford, UK) has launched GMP-grade StemFit ® for Differentiation, a chemically defined and animal component-free formulation that enables unmatched differentiation of human induced pluripotent ...
Researchers advance scalable stem-cell bioprocessing with AI-enabled manufacturing for regenerative medicine therapies.
BELTSVILLE, Md., March 3, 2026 /PRNewswire/ -- REPROCELL (TYO: 4978) today announced the launch of its US FDA compliant Good Manufacturing Practice (GMP) Master Cell Bank (MCB) manufacturing service ...
BELTSVILLE, Md., June 9, 2026 /PRNewswire/ -- REPROCELL (TYO: 4978) today announced that it has received a competitive Commercialization Award from the Maryland Stem Cell Research Fund (MSCRF). The ...
TULLINGE, Sweden & TAMPA, Fla.--(BUSINESS WIRE)--SmartCella Holding AB (“SmartCella”), a global biopharma company developing and manufacturing cutting-edge cell therapy approaches for ...
BioRestorative Therapies, Inc. (“BioRestorative,” “BRTX,” or the “Company”) (Nasdaq:BRTX), a late-stage clinical regenerative medicine company focused on stem cell-based therapies and products, today ...
Ernexa Therapeutics (Nasdaq: ERNA), an industry innovator developing novel cell therapies for the treatment of advanced cancer and autoimmune disease, today highlighted significant progress across ...
Syntax Bio, a synthetic biology company programming the next generation of cell therapies, and Applied StemCell Corp. (ASC), ...
Nanotein engages Akron Bio for the cGMP production of its NanoSpark™ STEM-T Soluble T Cell Activator
BERKELEY, Calif.--(BUSINESS WIRE)--Nanotein Technologies, Inc. (“Nanotein”), a technology development company with next-generation immune cell activation reagents leveraging its proprietary NanoSpark® ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results